MRAM-Announcement

NIH: Availability of Supplements on COVID-19

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

The National Heart, Lung, and Blood Institute (NHLBI) issued a notice to highlight the urgent need for research on COVID-19 and on the biological effects of SARS-CoV-2.

Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

NOT-HL-20-757:

Announcement Type

Guidance for NIH Funded Clinical Trials & Human Subjects Studies Affected by COVID-19

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

NIH has issued  guidance for clinical trials & human subjects studies impacted by COVID-19

This notice reinforces the importance NIH places on the health and safety of human participants and research staff. It also provides guidance on how to handle Delays in Research Progress as well as Unanticipated Costs as a result of COVID-19.

NOT-OD-20-087

Announcement Type

NSF Extends Some March Deadlines

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

NSF announced March deadline date extensions for some solicitations and Dear Colleague Letters (DCLs). Others may be added to the list and we strongly encourage you to check NSF’s Coronavirus website regularly. 

Thank you,
Carol Rhodes
Director
Office of Sponsored Programs

Announcement Type

Flexibilities for Applicants and Awardees due to COVID-19

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

The Dept. of Energy (DOE) has issued a Special Announcement for Applicants and Awardees announcing flexibilities due to COVID-19. The announcement details guidance and Q&A for COVID-19 challenges faced by DOE applicants and awardees. 
Topics covered include:

Announcement Type

NIH Announces Flexibilities for Applicants and Recipients Affected by COVID-19

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

NIH announced flexibilities for applicants and recipients affected by COVID-19 as well as accompanying FAQs.

These flexibilities are applicable to NIH applicants and recipients where the entity is conducting research activities related to or affected by COVID-19.

Announcement Type

CORE Announces In-Person Class Cancellations and Plans to Zoom

Member for

5 years 8 months
Submitted by mdavis25 on

Dear Colleagues,

As the University of Washington has been proactive with response to COVID-19, and the implementation of plans to move all instruction and exams out of the classroom, we in CORE feel the need to be similarly responsive. We will offer alternatives to our in-person classes until the situation with COVID-19 is resolved to the point where we can again safely resume these classes.

Announcement Type

NIH: COVID-19 FAQs and Late Submission Policy

Member for

5 years 8 months
Submitted by mdavis25 on

Greetings Colleagues,

When delays occur because an applicant organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting late applications, on a case-by-case basis.  

At this time, the University of Washington is not officially closed and we are able to submit applications. Review OSP's business continuity information

Announcement Type